AFIB Acutus Medical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AFIB

Price (delayed)

$0.5384

Market cap

$15.26M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.5

Enterprise value

$48.55M

Acutus Medical is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. Acutus is committed to advancing the field of electrophysiology with a unique ...

Highlights
AFIB's revenue has surged by 66% year-on-year
The EPS has soared by 86% YoY but it has contracted by 9% from the previous quarter
AFIB's gross profit has plunged by 70% YoY
Acutus Medical's equity has decreased by 35% QoQ and by 31% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.acutusmedical.com
Peers: NVRO OFIX NUVA

Key stats

What are the main financial stats of AFIB
Market
Shares outstanding
28.34M
Market cap
$15.26M
Enterprise value
$48.55M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.22
Price to sales (P/S)
0.87
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.8
Earnings
Revenue
$17.35M
EBIT
-$122.82M
EBITDA
-$115.62M
Free cash flow
-$108.39M
Per share
EPS
-$4.5
Free cash flow per share
-$3.85
Book value per share
$2.43
Revenue per share
$0.62
TBVPS
$4.51
Balance sheet
Total assets
$131.64M
Total liabilities
$62.88M
Debt
$45.77M
Equity
$68.76M
Working capital
$87.11M
Liquidity
Debt to equity
0.67
Current ratio
6.03
Quick ratio
4.49
Net debt/EBITDA
-0.29
Margins
EBITDA margin
-666.3%
Gross margin
-89.7%
Net margin
-740.6%
Operating margin
-723.2%
Efficiency
Return on assets
-80.4%
Return on equity
-133.9%
Return on invested capital
-83.3%
Return on capital employed
-107.4%
Return on sales
-707.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AFIB stock price

How has the Acutus Medical stock price performed over time
Intraday
-2.11%
1 week
9.63%
1 month
-21.58%
1 year
-96.88%
YTD
-84.21%
QTD
-61.27%

Financial performance

How have Acutus Medical's revenue and profit performed over time
Revenue
$17.35M
Gross profit
-$15.56M
Operating income
-$125.51M
Net income
-$128.52M
Gross margin
-89.7%
Net margin
-740.6%
AFIB's gross profit has plunged by 70% YoY
AFIB's revenue has surged by 66% year-on-year
The net margin is up by 31% year-on-year but it has declined by 9% since the previous quarter
Acutus Medical's operating margin has increased by 25% YoY but it has decreased by 8% QoQ

Growth

What is Acutus Medical's growth rate over time

Valuation

What is Acutus Medical stock price valuation
P/E
N/A
P/B
0.22
P/S
0.87
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.8
The EPS has soared by 86% YoY but it has contracted by 9% from the previous quarter
The price to book (P/B) is 91% lower than the last 4 quarters average of 2.4
Acutus Medical's equity has decreased by 35% QoQ and by 31% YoY
AFIB's P/S is 94% below its last 4 quarters average of 14.8
AFIB's revenue has surged by 66% year-on-year

Efficiency

How efficient is Acutus Medical business performance
AFIB's ROE has soared by 66% YoY but it is down by 18% from the previous quarter
The ROS has grown by 31% YoY but it has contracted by 9% from the previous quarter
The company's return on assets fell by 14% QoQ and by 14% YoY
AFIB's return on invested capital is down by 13% since the previous quarter and by 3% year-on-year

Dividends

What is AFIB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AFIB.

Financial health

How did Acutus Medical financials performed over time
Acutus Medical's total assets is 109% higher than its total liabilities
Acutus Medical's total assets has decreased by 22% QoQ and by 19% YoY
Acutus Medical's quick ratio has decreased by 21% QoQ and by 15% YoY
The debt is 33% smaller than the equity
The company's debt to equity has surged by 63% YoY and by 56% QoQ
Acutus Medical's equity has decreased by 35% QoQ and by 31% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.